Apolipoprotein-E (APOE) genotyping predicts Alzheimer's Disease (AD) with 100% accuracy in US study
This article was originally published in Clinica
Executive Summary
US researchers at Duke University Medical Center, North Carolina, found that apolipoprotein-E genotyping had a 100% positive predictive value in 57 demented patients confirmed by post mortem as having Alzheimer's disease. Reporting their results in the Lancet (July 13th), Prof A Roses and colleagues say that both the specificity and positive predictive value associated with the e4 allele were 100% for AD. None of the 10 demented non-AD patients carried the allele, while all the patients with APOE-e4 had AD. The negative predictive value was 42%.
You may also be interested in...
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.